BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6531748)

  • 1. Indium-111-labelled human platelets: a method for use in severe thrombocytopenia.
    Heyns Adu P; Badenhorst PN; Wessels P; Pieters H; Kotzè HF; Lötter MG
    Thromb Haemost; 1984 Dec; 52(3):226-9. PubMed ID: 6531748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of In-111-platelets in the baboon: I. Isolation and labelling of a viable and representative platelet population.
    Kotzé HF; Lötter MG; Badenhorst PN; Heyns AD
    Thromb Haemost; 1985 Jun; 53(3):404-7. PubMed ID: 4049310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet separation from the blood of severely thrombocytopaenic patients.
    Kazemi A; Westwood NB
    Med Lab Sci; 1991 Jul; 48(3):232-4. PubMed ID: 1787783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labelling autologous platelets with 111In tropolonate for platelet kinetic studies: limitations imposed by thrombocytopenia.
    Danpure HJ; Osman S; Peters AM
    Eur J Haematol; 1990 Oct; 45(4):223-30. PubMed ID: 2226740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.
    Wessels P; Heyns AD; Pieters H; Lötter MG; Badenhorst PN
    Eur J Nucl Med; 1985; 10(11-12):522-7. PubMed ID: 3928383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indium-III: a new radionuclide label for studying human platelet kinetics.
    Heaton WA; Davis HH; Welch MJ; Mathias CJ; Joist JH; Sherman LA; Siegel BA
    Br J Haematol; 1979 Aug; 42(4):613-22. PubMed ID: 476012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic kinetics of indium-111-labelled platelets.
    Peters AM; Saverymuttu SH; Malik F; Ind PW; Lavender JP
    Thromb Haemost; 1985 Oct; 54(3):595-8. PubMed ID: 3937258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of In-111-platelets in the baboon: II. In vitro distribution and sites of sequestration.
    Kotzé HF; Lötter MG; Badenhorst PN; Heyns AD
    Thromb Haemost; 1985 Jun; 53(3):408-10. PubMed ID: 4049311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional alterations of human platelets following indium-111 labelling using different incubation media and labelling agents.
    Isaka Y; Kimura K; Matsumoto M; Kamada T; Imaizumi M
    Eur J Nucl Med; 1991; 18(5):326-31. PubMed ID: 1936041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
    Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
    Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous platelet-labeling in thrombocytopenia.
    Sinzinger H; Virgolini I; Vinazzer H
    Thromb Res; 1990 Nov; 60(3):223-30. PubMed ID: 2084951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.
    Louwes H; Beekhuis H; Goedemans WT; Keijser SP; Schuurman JJ
    Eur J Nucl Med; 1987; 13(1):47-51. PubMed ID: 3109918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling of equine platelets in plasma with 111In-(2-mercaptopyridine-N-oxide) and their in vivo survival.
    Coyne CP; Kelly AB; Hornof WJ; O'Brien TR; Philp MS; Lamb JF
    Am J Vet Res; 1987 Mar; 48(3):385-91. PubMed ID: 3565893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of unmatched and HLA-matched 111in-labelled homologous platelets in recipients with chronic marrow hypoplasia and anti-platelet immunity.
    Peters AM; Porter JB; Saverymuttu SH; Malik F; Zuiable A; Lavender JP; Schwarz G; Lewis SM; Gordon-Smith EC
    Br J Haematol; 1985 May; 60(1):117-27. PubMed ID: 4005172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet volume in essential thrombopenia].
    Le Tohic F; Prost-Dvojakovic RJ; Le Menn R; Samama M
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):155-71. PubMed ID: 568255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet destruction.
    Neame PB; Hirsh J
    Semin Thromb Hemost; 1982 Apr; 8(2):75-82. PubMed ID: 6210959
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia.
    Schmidt KG; Rasmussen JW; Bekker C; Madsen PE
    Scand J Haematol; 1985 Jan; 34(1):39-46. PubMed ID: 3918341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative platelet imaging and comparison of four mathematical models for the evaluation of platelet mean life span in patients with chronic immune thrombocytopenia.
    Amuasi JH; Ferri P; Grossi A; Vannucchi L; Vannucchi AM; Ferrini PR
    Haematologica; 1991; 76(2):104-8. PubMed ID: 1937166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of the blood cell separator Haemonetic 30 in the separation of platelets from single donors].
    Gmür J; Hirvonen H; Fehr J; Honegger HP
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1452-3. PubMed ID: 918594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet function in acute myeloid leukemia. II. Aggregation of isolated platelets].
    Zawilska K; Komarnicki M; Mańka B
    Acta Haematol Pol; 1978; 9(3):187-92. PubMed ID: 281086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.